+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Glabridin CAS 59870-68-7 Market - Global Strategic Business Report

  • PDF Icon

    Report

  • 284 Pages
  • October 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6094894
The global market for Glabridin CAS 59870-68-7 was valued at US$27.5 Billion in 2024 and is projected to reach US$34.5 Billion by 2030, growing at a CAGR of 3.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Glabridin CAS 59870-68-7 market.

Global 'Glabridin (CAS 59870-68-7)' Market - Key Trends & Drivers Summarized

Why Is Glabridin Emerging as a High-Demand Ingredient in the Cosmetics and Health Industry?

Glabridin, a flavonoid compound extracted primarily from licorice root (Glycyrrhiza glabra), is rapidly gaining prominence in the global nutraceutical and cosmetics industries due to its potent skin-lightening, antioxidant, anti-inflammatory, and anti-aging properties. As consumer preference shifts toward naturally derived ingredients, glabridin stands out as a scientifically validated botanical alternative to synthetic actives like hydroquinone or kojic acid, especially in skincare formulations targeting hyperpigmentation, melasma, and uneven skin tone. The compound inhibits tyrosinase activity, which is responsible for melanin production, making it a go-to ingredient in brightening and whitening skincare products. In addition, glabridin is non-irritating, suitable for sensitive skin, and has demonstrated protective effects against UV-induced oxidative stress, further reinforcing its utility in anti-aging and sun care formulations. Beyond cosmetics, glabridin is also explored in functional foods and dietary supplements for its estrogenic, cardiovascular, and neuroprotective benefits. These applications are particularly relevant in markets focused on women's health and anti-menopausal support. The growing awareness of clean-label formulations, increased R&D into herbal actives, and rising disposable income in emerging economies are further boosting demand. As natural beauty and wellness trends become mainstream across Asia-Pacific, Europe, and North America, glabridin is carving out a niche as a premium bioactive with multifunctional health and cosmetic benefits.

What Are the Key Technological and Manufacturing Trends in the Glabridin Market?

Technological innovation in the extraction, purification, and formulation of glabridin is playing a critical role in enhancing its commercial value and scalability. Traditionally extracted from licorice root using ethanol or water-alcohol solvents, glabridin now benefits from advanced supercritical CO2 extraction methods that yield higher purity and retain bioactivity more effectively. These greener and more efficient extraction techniques align with rising regulatory and consumer demand for sustainable sourcing and environmentally friendly processing. In the realm of formulation, nanoencapsulation and liposomal delivery systems are being adopted to enhance glabridin's stability, bioavailability, and dermal absorption. These technologies help overcome challenges like low water solubility and potential degradation in topical applications. On the production side, biotech-based fermentation and plant cell culture techniques are emerging as potential alternatives to traditional farming and extraction, enabling controlled, consistent supply while minimizing environmental impact. Manufacturers are also developing standardized glabridin extracts with high active content (≥40%) to meet the purity requirements of pharmaceutical and cosmeceutical formulations. Stringent quality control and traceability mechanisms - especially for exports to Japan, South Korea, and the European Union - are increasingly being adopted to ensure compliance with safety and efficacy standards. These technological advancements not only improve product performance but also allow suppliers to meet the growing demand for high-quality, clean-label ingredients in a competitive global market.

How Are End-Use Sectors and Geographic Markets Influencing Demand Patterns?

The glabridin market is driven by strong demand from several key end-use sectors, notably cosmetics and personal care, dietary supplements, and pharmaceuticals. In cosmetics, glabridin is used extensively in skin whitening creams, anti-aging serums, sunscreens, and post-acne recovery products - making the personal care sector the largest consumer of this compound. Asia-Pacific remains the dominant market due to cultural emphasis on skin brightness and even complexion, with countries like South Korea, China, Japan, and India leading in product launches containing glabridin. Western markets, particularly in Europe and North America, are seeing increased adoption of glabridin in clean beauty and plant-based cosmeceuticals, often marketed as part of premium anti-aging and sensitive skin product lines. In the nutraceutical sector, glabridin is incorporated into supplements aimed at managing metabolic syndrome, menopause symptoms, and cardiovascular health, appealing particularly to aging populations. Pharmaceutical research is also exploring glabridin for potential applications in inflammatory disorders and hormone-related conditions, although these remain largely in the investigational stages. In terms of distribution, both B2B (bulk extract suppliers, cosmetic ingredient companies) and B2C (finished product brands) channels are expanding. Regulatory clarity around botanical extracts in China, the EU, and the U.S. is further facilitating market entry and product approvals. E-commerce growth is accelerating demand across borders, as consumers increasingly seek natural actives with clinical backing. This convergence of industry innovation and regional dynamics is reshaping how glabridin is positioned and consumed globally.

What Factors Are Fueling Growth in the Global Glabridin Market?

The growth in the glabridin (CAS 59870-68-7) market is driven by several interconnected factors tied to industry shifts, consumer behavior, and innovation in product formulation. Foremost is the rising global demand for natural, plant-derived cosmetic actives that offer effective skin benefits without the adverse effects associated with synthetic ingredients. As consumers become more ingredient-conscious, glabridin's proven efficacy in reducing pigmentation and oxidative stress offers a strong value proposition. Second, the increasing popularity of anti-aging and skin-brightening products - particularly in Asia-Pacific and the Middle East - is fueling demand for high-efficacy botanical ingredients, with glabridin positioned as a premium option. Third, the expansion of functional food and supplement markets - driven by the aging population and interest in hormonal balance and metabolic health - is opening new use cases for glabridin in ingestible formats. On the supply side, advancements in extraction and bioengineering technologies are improving cost-efficiency and scalability, allowing manufacturers to meet rising global demand while maintaining high purity standards. The proliferation of clean-label and vegan-certified products is also creating a favorable regulatory and consumer environment for botanical ingredients like glabridin. Additionally, brand investments in R&D, clinical validation, and marketing are strengthening the credibility and visibility of glabridin-based formulations. Finally, international trade in herbal ingredients is expanding, supported by global sourcing hubs in China, India, and Central Europe. These combined drivers are positioning glabridin as a high-growth ingredient in the broader natural cosmetics and nutraceuticals market, with strong future potential across both established and emerging economies.

Report Scope

The report analyzes the Glabridin CAS 59870-68-7 market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Type (HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent, HPLC 98 percent); Application (Cosmetics Application, Pharmaceuticals Application).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the HPLC 20 percent segment, which is expected to reach US$12.3 Billion by 2030 with a CAGR of a 4.9%. The HPLC 40 percent segment is also set to grow at 3.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $7.5 Billion in 2024, and China, forecasted to grow at an impressive 7.3% CAGR to reach $7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Glabridin CAS 59870-68-7 Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Glabridin CAS 59870-68-7 Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Glabridin CAS 59870-68-7 Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 44 companies featured in this Glabridin CAS 59870-68-7 market report include:

  • AIDP, Inc.
  • Alchem International
  • Alfa Chemicals
  • Anthony Ingredients
  • BOC Sciences
  • Botanic Innovations
  • ChemFaces
  • Chromadex, Inc.
  • CP Kelco
  • Euromed S.A.
  • FloraTech
  • Galaxy Surfactants
  • Givaudan
  • Guangxi Wuzhou Zhongheng Bio-Tech
  • Hebei Yele Biotechnology
  • Indena S.p.A.
  • Jiangxi Shenzhou Biological
  • Layn Natural Ingredients
  • Lonza Group AG
  • Natreon, Inc.

This edition integrates the latest global trade and economic shifts into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes historical analysis from 2015 to 2023.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Glabridin CAS 59870-68-7 - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Natural Skin-Lightening Agents Drives Adoption of Glabridin in Cosmetics
  • Growth in Clean Beauty and Botanical Ingredients Strengthens Market for Glabridin-Based Products
  • Scientific Research Validating Anti-Inflammatory Properties Throws Spotlight on New Therapeutic Uses
  • Expansion of Nutricosmetics Segment Accelerates Formulation of Oral Glabridin Supplements
  • Increased Consumer Preference for Non-Hydroquinone Solutions Sustains Demand for Safe Alternatives
  • Regulatory Acceptance of Plant-Based Actives Enhances Formulation Flexibility for Manufacturers
  • Growth in K-Beauty and Functional Skincare Trends Propels Use of Flavonoid-Based Ingredients
  • Limited Raw Material Sources and Cost of Purification Create Challenges in Large-Scale Production
  • Formulation Synergies with Vitamin C and Niacinamide Expand Glabridins Multi-Functional Appeal
  • E-Commerce and Indie Brand Growth Drive Inclusion in Niche Skincare Lines
  • Research into Antioxidant and Estrogenic Properties Expands Opportunities in Wellness Applications
  • High Purity Ingredient Demand from Global Markets Encourages Standardized Extraction Practices
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Glabridin CAS 59870-68-7 Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for HPLC 20 percent by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for HPLC 20 percent by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for HPLC 20 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for HPLC 40 percent by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for HPLC 40 percent by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for HPLC 40 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for HPLC 60 percent by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for HPLC 60 percent by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for HPLC 60 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for High-Performance Liquid Chromatography 90 percent by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for High-Performance Liquid Chromatography 90 percent by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for High-Performance Liquid Chromatography 90 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for HPLC 98 percent by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for HPLC 98 percent by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for HPLC 98 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Cosmetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Cosmetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Cosmetics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Pharmaceuticals Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 27: USA Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: USA 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 29: USA Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 30: USA Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: USA 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 33: Canada Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: Canada 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 35: Canada Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 36: Canada Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: Canada 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
JAPAN
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 39: Japan Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 40: Japan 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 41: Japan Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 42: Japan Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 43: Japan 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
CHINA
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 44: China Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 45: China Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 46: China 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 47: China Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 48: China Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 49: China 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
EUROPE
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 51: Europe Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 52: Europe 13-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 53: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 54: Europe Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 55: Europe 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 56: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 57: Europe Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 58: Europe 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
FRANCE
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 59: France Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 60: France Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 61: France 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 62: France Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 63: France Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 64: France 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
GERMANY
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 65: Germany Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 66: Germany Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 67: Germany 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 68: Germany Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 69: Germany Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 70: Germany 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
ITALY
  • Table 71: Italy Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 72: Italy Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 73: Italy 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 74: Italy Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 75: Italy Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 76: Italy 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 77: UK Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 78: UK Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 79: UK 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 80: UK Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 81: UK Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 82: UK 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
SPAIN
  • Table 83: Spain Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 84: Spain Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 85: Spain 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 86: Spain Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 87: Spain Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 88: Spain 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
RUSSIA
  • Table 89: Russia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 90: Russia Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 91: Russia 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 92: Russia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 93: Russia Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 94: Russia 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 96: Rest of Europe Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 97: Rest of Europe 13-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2020, 2026 & 2032
  • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 99: Rest of Europe Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 100: Rest of Europe 13-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2020, 2026 & 2032
AUSTRALIA
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
  • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AIDP, Inc.
  • Alchem International
  • Alfa Chemicals
  • Anthony Ingredients
  • BOC Sciences
  • Botanic Innovations
  • ChemFaces
  • Chromadex, Inc.
  • CP Kelco
  • Euromed S.A.
  • FloraTech
  • Galaxy Surfactants
  • Givaudan
  • Guangxi Wuzhou Zhongheng Bio-Tech
  • Hebei Yele Biotechnology
  • Indena S.p.A.
  • Jiangxi Shenzhou Biological
  • Layn Natural Ingredients
  • Lonza Group AG
  • Natreon, Inc.

Table Information